» Articles » PMID: 34692360

Dermatologic Manifestations of Endocrine Disorders

Overview
Journal Cureus
Date 2021 Oct 25
PMID 34692360
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Endocrine disorders are known to involve all organ systems of the body, including the skin. The cutaneous manifestations of endocrine disorders can range from common findings such as acanthosis nigricans, pretibial myxedema, acne, hirsutism, hyper or hypopigmentation to rare cutaneous findings such as miliaria rubra, calciphylaxis, lentigines, and calcinosis cutis. These cutaneous symptoms can sometimes be the presenting symptoms or can even be pathognomonic of the underlying endocrine condition. In some cases, the cutaneous symptoms from an underlying endocrine abnormality may be the most prominent. These symptoms can significantly affect the quality of life of individuals. Often, individuals may seek health care from a dermatologist or primary care physician for isolated skin symptoms. Therefore, it is imperative for physicians to recognize the skin symptoms as the manifestation of the endocrine disorder for prompt diagnosis and treatment of the underlying endocrine disorder.

Citing Articles

Acanthosis Nigricans in a Patient with Urothelial Carcinoma Treated with PD-L1 Inhibitor Avelumab, and Secondary Adrenal Insufficiency.

Lai F, Jordan E Case Rep Oncol. 2023; 16(1):1107-1112.

PMID: 37900822 PMC: 10601793. DOI: 10.1159/000533758.


Cutaneous lesions and other non-endocrine manifestations of Multiple Endocrine Neoplasia type 1 syndrome.

Pierotti L, Pardi E, Dinoi E, Piaggi P, Borsari S, Della Valentina S Front Endocrinol (Lausanne). 2023; 14:1191040.

PMID: 37484956 PMC: 10360178. DOI: 10.3389/fendo.2023.1191040.


Investigating material basis and molecular mechanism of Qing Cuo formula in the treatment of acne based on animal experiments, UPLC-LTQ-Orbitrap-MS and network pharmacology.

Cao Y, Liang J, Wang C, Bao X, Li S, Liu Q Pharm Biol. 2023; 61(1):973-985.

PMID: 37390845 PMC: 10316743. DOI: 10.1080/13880209.2023.2225546.


Dermatologic manifestations of thyroid disease: a literature review.

Cohen B, Cadesky A, Jaggi S Front Endocrinol (Lausanne). 2023; 14:1167890.

PMID: 37251685 PMC: 10214500. DOI: 10.3389/fendo.2023.1167890.


Type 1 Diabetes Mellitus and Autoimmune Diseases: A Critical Review of the Association and the Application of Personalized Medicine.

Popoviciu M, Kaka N, Sethi Y, Patel N, Chopra H, Cavalu S J Pers Med. 2023; 13(3).

PMID: 36983604 PMC: 10056161. DOI: 10.3390/jpm13030422.


References
1.
Asgharian B, Turner M, Gibril F, Entsuah L, Serrano J, Jensen R . Cutaneous tumors in patients with multiple endocrine neoplasm type 1 (MEN1) and gastrinomas: prospective study of frequency and development of criteria with high sensitivity and specificity for MEN1. J Clin Endocrinol Metab. 2004; 89(11):5328-36. DOI: 10.1210/jc.2004-0218. View

2.
Simi S, Narayanan B, Nandakumar G . Not just skin deep: a case report of multiple endocrine neoplasia type 1. Indian J Dermatol. 2012; 57(4):304-7. PMC: 3401852. DOI: 10.4103/0019-5154.97679. View

3.
Safer J . Thyroid hormone action on skin. Dermatoendocrinol. 2011; 3(3):211-5. PMC: 3219173. DOI: 10.4161/derm.3.3.17027. View

4.
de Laat J, van der Luijt R, Pieterman C, Oostveen M, Hermus A, Dekkers O . MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients. BMC Med. 2016; 14(1):182. PMC: 5109674. DOI: 10.1186/s12916-016-0708-1. View

5.
Rothenbuhler A, Stratakis C . Clinical and molecular genetics of Carney complex. Best Pract Res Clin Endocrinol Metab. 2010; 24(3):389-99. DOI: 10.1016/j.beem.2010.03.003. View